biote Corp. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- biote Corp. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $226.00K, a 5.04% decline year-over-year.
- biote Corp. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $247.00K.
- biote Corp. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $238.00K.
- biote Corp. stock issued during period, value, stock options exercised for the quarter ending 2024-03-31 was $324.00K, a 22.86% decline year-over-year.
- biote Corp. stock issued during period, value, stock options exercised for fiscal 2024 was $2.39M, a 469.05% increase from fiscal 2023.
- biote Corp. stock issued during period, value, stock options exercised for fiscal 2023 was $420.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-06-30 | $226.00K 10-Q · filed 2025-11-07 | |
| 2024-12-31 | $2.39M 10-K · filed 2025-03-14 | |
| 2024-09-30 | $247.00K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $238.00K 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $324.00K 10-Q · filed 2025-11-07 | |
| 2023-12-31 | $420.00K 10-K · filed 2025-03-14 | |
| 2023-03-31 | $420.00K 10-Q · filed 2024-11-12 |